These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 1547391)

  • 1. Increased prescription of thrombolytic treatment to elderly patients with suspected acute myocardial infarction associated with audit.
    Hendra TJ; Marshall AJ
    BMJ; 1992 Feb; 304(6824):423-5. PubMed ID: 1547391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Atenolol i.v. in the acute phase of AMI: the indications, contraindications and interactions with thrombolytic drugs in the GISSI-2 study. The GISSI-2 Researchers. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
    Mafrici A; Mauri F; Maggioni AP; Franzosi MG; Santoro L; De Vita C
    G Ital Cardiol; 1995 Mar; 25(3):353-64. PubMed ID: 7642042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An audit of thrombolytic therapy in a rural hospital.
    Cohen S; Gibb S
    Aust Fam Physician; 1993 Oct; 22(10):1866-8. PubMed ID: 8280016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
    Barbash GI; White HD; Modan M; Van de Werf F
    J Am Coll Cardiol; 1993 Sep; 22(3):707-13. PubMed ID: 8354802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary care follow-up study: acute care required immediately following thrombolytic therapy.
    Ellicott C; Shaw DB; Kirby BJ; Bailey T
    J R Soc Med; 1993 Jun; 86(6):324-7. PubMed ID: 8315624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombolysis for elderly patients with myocardial infarction: experience in an integrated unit.
    Batty GM; Parry DS; Wilkins WE; Chappell AG
    Age Ageing; 1994 May; 23(3):220-2. PubMed ID: 8085507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of thrombolytic therapy in patients presenting to a peripheral metropolitan emergency department with acute myocardial infarction.
    Jacobs IG; Fatovich DM
    Aust N Z J Med; 1996 Aug; 26(4):539-42. PubMed ID: 8873938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction.
    Krumholz HM; Pasternak RC; Weinstein MC; Friesinger GC; Ridker PM; Tosteson AN; Goldman L
    N Engl J Med; 1992 Jul; 327(1):7-13. PubMed ID: 1598117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Are ECG criteria for indications for thrombolysis in acute myocardial infarct defined too narrowly?].
    Weiss P; Sarasin C; Ritz R; Pfisterer M
    Schweiz Med Wochenschr; 1991 Dec; 121(49):1829-32. PubMed ID: 1754866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-hospital thrombolytic therapy with either alteplase or streptokinase. Practical applications, complications and long-term results in 529 patients.
    Grijseels EW; Bouten MJ; Lenderink T; Deckers JW; Hoes AW; Hartman JA; van der Does E; Simoons ML
    Eur Heart J; 1995 Dec; 16(12):1833-8. PubMed ID: 8682015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thrombolytic therapy in acute myocardial infarct--is it being used to the fullest?].
    Carôla B; Calçada-Correia L; Pedro PG; Conduto R; Dionísio I; Fiuza M; Dias E; Vaz Carneiro A; Amador MG; de Pádua F; Lopes MG
    Rev Port Cardiol; 1996 Dec; 15(12):867-76, 863. PubMed ID: 9052962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost, uncertainty, and doctors' decisions. The case of thrombolytic therapy.
    Lessler DS; Avins AL
    Arch Intern Med; 1992 Aug; 152(8):1665-72. PubMed ID: 1497400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Streptokinase-induced hypotension has no detrimental effect on patients with thrombolytic treatment for acute myocardial infarction. A substudy of the Romanian Study for Accelerated Streptokinase in Acute Myocardial Infarction (ASK-ROMANIA).
    Tatu-Chiţoiu G; Teodorescu C; Dan M; Guran M; Căpraru P; Istrăţescu O; Tatu-Chiţoiu A; Bumbu A; Chioncel V; Arvanitopol S; Dorobanţu M
    Rom J Intern Med; 2004; 42(3):557-73. PubMed ID: 16366130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
    GUSTO investigators
    N Engl J Med; 1993 Sep; 329(10):673-82. PubMed ID: 8204123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines for the use of intravenous thrombolytic agents in acute myocardial infarction. Ontario Medical Association Consensus Group on Thrombolytic Therapy.
    Naylor CD; Armstrong PW
    CMAJ; 1989 Jun; 140(11):1289-99. PubMed ID: 2497946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antecedent angina pectoris predicts worse outcome after myocardial infarction in patients receiving thrombolytic therapy: experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
    Barbash GI; White HD; Modan M; Van de Werf F
    J Am Coll Cardiol; 1992 Jul; 20(1):36-41. PubMed ID: 1607536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of emergency cardiac enzymes: audit in a coronary care unit.
    Lewis F; Jishi F; Sissons CE; Baker JT; Child DF
    J R Soc Med; 1991 Jul; 84(7):398-9. PubMed ID: 1865444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection factors for the use of thrombolytic treatment in acute myocardial infarction: a population based study of current practice in the United Kingdom. The European Secondary Prevention Study Group.
    Ketley D; Woods KL
    Br Heart J; 1995 Sep; 74(3):224-8. PubMed ID: 7547014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.